PTC
EBS icon

Private Trust Company’s Emergent Biosolutions EBS Stock Holding History

Private Trust Company’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-125
Closed -$3K – 529
2014
Q3 		$3K Hold
125
– – ﹤0.01% 1452
2014
Q2 		$3K Buy
125
+16
+15% +$373 ﹤0.01% 1461
2014
Q1 		$3K Buy
+109
New +$2.75K ﹤0.01% 1339

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Private Trust Company's EBS Position: Q4 2014 in Review

Private Trust Company sold out of Emergent Biosolutions (EBS) in Q4 2014, closing a stake of 125 shares — an estimated $3K sold.

Private Trust Company first reported a position in EBS in Q1 2014 and held it in 3 quarters. The position peaked at $3K in Q3 2014. 167 funds tracked by Wall St. Rank hold EBS as of Q4 2014.

  • Private Trust Company reported no remaining Emergent Biosolutions position as of Q4 2014 after selling out during the quarter.
  • Private Trust Company sold 125 Emergent Biosolutions shares in Q4 2014, an estimated $3K.
  • Private Trust Company first reported a position in Emergent Biosolutions in Q1 2014 and held it in 3 quarters.
  • Private Trust Company's Emergent Biosolutions position peaked at $3K in Q3 2014.
  • 167 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.